Aptevo Therapeutics Inc
Biotechnology Research • 
Seattle, Washington, United States • 51-100 Employees
Company overview
| Headquarters | 2401 4th Avenue, Suite 1050, Seattle, WA 98101, US |
| Phone number | +12068380500 |
| Websites | |
| NAICS | 541714 |
| SIC | 283 |
| Founded | 2016 |
| Employees | 51-100 |
| Socials |
Key Contacts at Aptevo Therapeutics Inc
Grady Grant
Board Of Directors – Compensation & Audit Committees » Compliance | Financial Reporting
Noor Khaskhely
Sr. Medical Director
Mark Honda
Sr. Director, Human Resources
Lynn Bonham
Senior Director Translational Pharmacology
Natalia Luiza Silva
Sales Director
Akmal Abdulmuminov
Director, Finance
Michelle Nelson
Director
John Kumer
Director Of Process Development, Head Of Analytical Sciences, Bioassay, And Qc
Sally Gould
Senior Director, Regulatory Affairs
Amy Eisenfeld
Director Medical Affairs
Aptevo Therapeutics Inc Email Formats
Aptevo Therapeutics Inc uses 1 email format. The most common is {first name}{last name} (e.g., johndoe@apvo.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@apvo.com | 100% |
About Aptevo Therapeutics Inc
Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. We leverage the innovative ADAPTIR™ platform technology, a unique approach to cancer immunotherapy, to improve outcomes for cancer patients. Based in Seattle, Washington, the company is proud of its empowering work environment, entrepreneurial culture, and proprietary platform technology. As a result, Aptevo has been able to attract some of the most innovative minds in the field. Many of our team members have notable experience with other pioneering biotech companies including Trubion, ZymoGenetics, Immunex, Dendreon, and VLST. At Aptevo Therapeutics, our core values of ownership and collaboration—combined with a history of innovation, dedication, and development—are positioning Aptevo Therapeutics to develop the science of what’s next in biotechnology.
Aptevo Therapeutics Inc revenue & valuation
| Annual revenue | $3,114,000 |
| Revenue per employee | $54,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $10,000,000 |
| Total funding | $33,700,000 |
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Aptevo Therapeutics Inc has 27 employees across 10 departments.
Departments
Number of employees
Funding Data
Explore Aptevo Therapeutics Inc's funding history, including investment rounds, total capital raised, and key backers.
Funding Insights
$33,700,000
Total funding amount
$8,000,000
Most recent funding amount
8
Number of funding rounds
Aptevo Therapeutics Inc Tech Stack
Discover the technologies and tools that power Aptevo Therapeutics Inc's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Video players
JavaScript libraries
Caching
JavaScript libraries
Maps
Analytics
JavaScript libraries
Web servers
JavaScript libraries
Programming languages
Blogs
United Kingdom
India
Frequently asked questions
4.8
40,000 users
